Park JC, Durbeck J, Clark JR, Faden DL, et al. Treatment sequence of cetuximab and immune checkpoint inhibitor in head and neck squamous cell carcinoma differentially affects outcomes. Oral Oncol 2020;111:105024.
PMID: 33065374